Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-09 · accession 0001765581-22-000138 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-13 | 2022-12-09 | JAZZ | Iannone Robert | EVP, Gbl Head of R, D | S - Sale | $151.54 | -1,844 | 36.3K | -5% | -$279.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-12-09 | S | D | 1,844 | $151.54 | 36,316 | D | — | — | (F1) Includes 51 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2022. |